SGHT — Sight Sciences Income Statement
0.000.00%
Last trade - 00:00- $157.67m
- $76.67m
- $79.87m
Annual income statement for Sight Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 27.6 | 49 | 71.3 | 81.1 | 79.9 |
| Cost of Revenue | |||||
| Gross Profit | 18.4 | 40.3 | 59 | 69.2 | 68.3 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 59.8 | 100 | 155 | 138 | 132 |
| Operating Profit | -32.2 | -51.5 | -84 | -57.3 | -52.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -34.6 | -62.8 | -86.2 | -55.4 | -51.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -34.7 | -63 | -86.2 | -55.5 | -51.5 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -34.7 | -63 | -86.2 | -55.5 | -51.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -34.7 | -63 | -86.2 | -55.5 | -51.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.77 | -2.36 | -1.8 | -1.14 | -1 |